FullDNA

FullDNA appears to be a legitimate but niche health-tech SME operating in Brazil and Israel, focusing on genetic algorithms and predictive health reports. However, the project submission is severely compromised by demonstrably false traction claims (claiming 'most people' have used the product) and confusing financial metrics ('marketcap' listed as revenue). While the underlying technology (bioinformatics/AI) has real-world utility, the lack of verifiable mass adoption and the low-quality submission drag the score down significantly compared to established benchmarks.